Minimizing Weapons-Usable Nuclear Material: A Nuclear Security Success Story Still in Progress
One of the most significant achievements in reducing the risk of nuclear terrorism over the past two decades is something that rarely makes headlines.
Risky Business
Welcome to the blog
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Get To Know NTI: Amanda Krieger
Humidity, Hard Truths, and the Future of Global Health Security
A Simple Step to Close a Dangerous Biosecurity Gap
Three Strikes: Why Giving Up on the NPT Is Not an Option
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI | bio Advances International Dialogue on AI Biosecurity Through Expert Working Groups
NTI | bio convened two technical working groups this fall to address critical challenges at the intersection of AI and the life sciences, bringing together more than 50 international experts from major AI companies, academic institutions, and biosecurity organizations.
Get to Know NTI: Aparupa Sengupta
Aparupa Sengupta, senior program officer for NTI’s Global Biological Policy and Programs team (NTI | bio), sat down with NTI’s Mary Fulham for the latest in Atomic Pulse’s “Get to Know NTI” series.
NTI Seminar: Alta Charo on the Future of Genome Editing
The Future of Genome Editing: Alta Charo Presents with NTI Seminar Series
NTI | bio Explores Ways to Enhance Disease Surveillance Through Next Generation DNA Sequencing
NTI | bio Explores Ways to Enhance Disease Surveillance Through Next Generation DNA Sequencing
Democratization of Synthetic Biology: Implications for Biosecurity and Pandemic Threats
Democratization of Synthetic Biology: Implications for Biosecurity and Pandemic Threats
Risky Business is edited by:
Scott Nolan Smith
Senior Director, Communications
Mary Olney Fulham
Director, Communications